Mazdutide 6mg

Original price was: $100.00.Current price is: $90.00.

Buy Mazdutide 6mg Online

The Definitive Dual-Agonist for Synergistic GLP-1R and GCGR Metabolic Signaling. Mazdutide is a specialized long-acting synthetic peptide functioning as a master regulator of energy homeostasis through balanced activation of the glucagon-like peptide-1 and glucagon receptors. The Polaris Peptides Labs provides this foundational ligand with guaranteed structural integrity and discreet shipping for institutional security. Every batch is high-purity verified for structural integrity, ensuring your research is supported by a full COA and uncompromising molecular precision.


SKU: PLMZ6 Category:

Mazdutide 6mg: Investigating the Pillars of Incretin and Glucagon Receptor Peptides

Introduction

In the landscape of modern molecular biology, the simultaneous modulation of multiple metabolic pathways represents a critical frontier in addressing systemic metabolic dysfunction. Researchers looking to buy Mazdutide online trust Polaris Peptides for high-fidelity sequences that remain stable under rigorous laboratory conditions. As a vital tool in the study of thermogenesis and glucose homeostasis, Mazdutide serves as a primary substrate for investigating the bypass of traditional monotherapy limitations.

What is Mazdutide?

Mazdutide (IBI362) is a synthetic oxyntomodulin analog engineered with a $C_{18}$ fatty acid side chain to facilitate extended pharmacokinetic stability. It functions as a potent dual-agonist, specifically designed to activate both the GLP-1 receptor (GLP-1R) and the glucagon receptor (GCGR) with a ratio optimized for laboratory research into lipid metabolism and satiety.

How Does Mazdutide 6mg Work in Laboratory Research?

Investigating Mazdutide Lab Results requires an objective analysis of its interactions with transmembrane receptors and intracellular signaling cascades:

  • Dual-Pathway Receptor Agonism: Mazdutide binds with high affinity to GLP-1R and GCGR, providing a model to investigate the counterbalance of insulinotropic effects against glucagon-mediated hepatic glucose output.

  • Mitochondrial Bioenergetics Induction: Research focuses on the peptide’s capacity to upregulate fatty acid oxidation, Investigating the subsequent impact on thermogenesis and resting energy expenditure.

  • cAMP Pathway Synergism: The polaris peptides sequence is studied for its ability to stimulate adenylyl cyclase across multiple tissue types, facilitating the study of downstream secondary messenger cascades in metabolic models.

  • Inhibition of Lipogenesis: Study of the polaris peptides tirzepatide-class comparator involves analyzing the downregulation of transcriptional activity related to hepatic fat accumulation.

Weight/Mass

5mg